CVRx, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CVRx, Inc. (CVRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 241.34 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 187.79K shares, a 71.05% increase year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 53.55K shares, a 60.69% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 100.77K shares, a 33.43% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 125.02K shares, a 39.53% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 471.79K shares, a 71.67% decline from fiscal 2024.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.67M shares, a 482.90% increase from fiscal 2023.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 285.73K shares, a 13.13% decline from fiscal 2022.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 328.90K shares, a 331.10% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 187.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 241.34K shares 10-Q · filed 2026-08-06 | 342.11K shares derived: sum of 3 quarters · filed 2026-08-06 | 467.13K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 53.55K shares 10-Q · filed 2026-05-12 | 154.32K shares derived: sum of 2 quarters · filed 2026-05-12 | 279.33K shares derived: sum of 3 quarters · filed 2026-05-12 | 389.12K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 100.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 225.78K shares derived: sum of 2 quarters · filed 2026-02-13 | 335.57K shares derived: sum of 3 quarters · filed 2026-02-13 | 471.79K shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 125.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 234.81K shares derived: sum of 2 quarters · filed 2025-11-06 | 371.02K shares 10-Q · filed 2025-11-06 | 522.38K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | 109.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 246.00K shares 10-Q · filed 2025-08-05 | 397.37K shares derived: sum of 3 quarters · filed 2026-02-13 | 604.12K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | 136.21K shares 10-Q · filed 2025-05-09 | 287.58K shares derived: sum of 2 quarters · filed 2026-02-13 | 494.33K shares derived: sum of 3 quarters · filed 2026-02-13 | 621.41K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | 151.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 358.12K shares derived: sum of 2 quarters · filed 2026-02-13 | 485.20K shares derived: sum of 3 quarters · filed 2026-02-13 | 1.67M shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 206.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 333.84K shares derived: sum of 2 quarters · filed 2024-11-01 | 1.51M shares 10-Q · filed 2024-11-01 | 1.54M shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-06-30 | 127.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 1.31M shares 10-Q · filed 2024-08-02 | 1.33M shares derived: sum of 3 quarters · filed 2025-02-18 | 1.41M shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | 1.18M shares 10-Q · filed 2024-05-10 | 1.20M shares derived: sum of 2 quarters · filed 2025-02-18 | 1.28M shares derived: sum of 3 quarters · filed 2025-02-18 | 1.33M shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | 21.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 97.83K shares derived: sum of 2 quarters · filed 2025-02-18 | 153.22K shares derived: sum of 3 quarters · filed 2025-02-18 | 285.73K shares 10-K · filed 2025-02-18 |
| 2023-09-30 | 76.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 131.66K shares derived: sum of 2 quarters · filed 2023-10-31 | 264.16K shares 10-Q · filed 2023-10-31 | 282.28K shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 55.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 187.90K shares 10-Q · filed 2023-08-03 | 206.02K shares derived: sum of 3 quarters · filed 2023-08-03 | 276.25K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 132.50K shares 10-Q · filed 2023-05-11 | 150.63K shares derived: sum of 2 quarters · filed 2023-05-11 | 220.86K shares derived: sum of 3 quarters · filed 2023-05-11 | 457.57K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 18.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 88.35K shares derived: sum of 2 quarters · filed 2023-02-10 | 325.07K shares derived: sum of 3 quarters · filed 2023-02-10 | 328.90K shares 10-K · filed 2023-02-10 |
| 2022-09-30 | 70.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | 306.94K shares derived: sum of 2 quarters · filed 2022-11-04 | 310.78K shares 10-Q · filed 2022-11-04 | 344.40K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-06-30 | 236.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | 240.55K shares 10-Q · filed 2022-08-01 | 274.17K shares derived: sum of 3 quarters · filed 2023-02-10 | 298.22K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-03-31 | 3.84K shares 10-Q · filed 2022-05-02 | 37.46K shares derived: sum of 2 quarters · filed 2023-02-10 | 61.51K shares derived: sum of 3 quarters · filed 2023-02-10 | |
| 2021-12-31 | 33.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 57.67K shares derived: sum of 2 quarters · filed 2023-02-10 | 76.29K shares 10-K · filed 2023-02-10 | |
| 2021-09-30 | 24.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | 42.67K shares 10-Q · filed 2021-11-08 | ||
| 2021-06-30 | 18.62K shares 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | 10.18K shares 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |